Last updated on September 2018

A Study to Evaluate the Efficacy and Safety of RO6867461 in Participants With Diabetic Macular Edema (YOSEMITE)


Brief description of study

This study will evaluate the efficacy, safety, and pharmacokinetics of RO6867461 administered at 8-week intervals or as specified in the protocol following treatment initiation, compared with aflibercept once every 8 weeks (Q8W), in participants with diabetic macular edema (DME).

Clinical Study Identifier: NCT03622580

Contact Investigators or Research Sites near you

Start Over

Reference Study ID Number: GR40349 ...

Fondation Rothschild; Ophtalmologie
Paris Cedex 19, France
5.52miles
  Connect »

Reference Study ID Number: GR40349 ...

Hopital Lariboisiere; Ophtalmologie
Paris, France
6.41miles
  Connect »

Reference Study ID Number: GR40349 ...

Centre Odeon; Exploration Ophtalmologique
Paris, France
8.67miles
  Connect »